HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin
Dulaglutide and renal protection in type 2 diabetes
When you take a GLP-1 agonist , the appetite suppression can be profound
After reviewing my case, we decided to transition to a physician-supervised tirzepatide treatment program with individualized dose escalation, scheduled follow-up appointments, and ongoing clinical monitoring
Gastroenterology 130 , 15641572 (2006)
nausea, fruity breath, confusion) Uncontrolled binge eating Severe anxiety, low mood, or thoughts of self-harm Rapid weight gain with no explanation Your Personal Withdrawal Plan: A Checklist Before Stopping: Discuss timeline with healthcare provider Schedule regular follow-up appointments Plan blood sugar monitoring schedule (if diabetic) Prepare meal plans and grocery lists Identify support systems and resources Set realistic expectations and goals Consider alternative treatment options During Withdrawal: Daily weight tracking (optional, based on personal preference) Blood sugar logs (if diabetic) Appetite and hunger level tracking Mood and energy level notes Physical activity records Medication adherence for other conditions For Long-Term Success: Regular healthcare provider check-ins Sustainable eating pattern establishment Consistent exercise routine Stress management practices Support group participation Realistic goal reassessment Summary Withdrawal from GLP-1 injections is safe when guided by a healthcare professional
